Loading…

Hickman catheter infections in patients with malignancies

The infectious complications associated with implantation of 1,088 Hickman catheters (HCs) in 992 patients reported in 18 published series are presented (including data on 129 previously unreported HCs from our own institution). HCs allow reliable long-term venous access (mean, 92.4 days) with low c...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore) 1984-07, Vol.63 (4), p.189-200
Main Authors: Press, O W, Ramsey, P G, Larson, E B, Fefer, A, Hickman, R O
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c360t-444af51e6ee8c89da298c25583a15a6a5185cf0c8d62332b0aadd0bf5036c63f3
cites
container_end_page 200
container_issue 4
container_start_page 189
container_title Medicine (Baltimore)
container_volume 63
creator Press, O W
Ramsey, P G
Larson, E B
Fefer, A
Hickman, R O
description The infectious complications associated with implantation of 1,088 Hickman catheters (HCs) in 992 patients reported in 18 published series are presented (including data on 129 previously unreported HCs from our own institution). HCs allow reliable long-term venous access (mean, 92.4 days) with low complication and infection rates (0.30 and 0.14 cases per 100 catheter days, respectively). Exit site infections were the most common form of infection encountered (45.5%), followed by septicemia alone (30.8%), tunnel infections (20.3%), and septic thrombophlebitis (3.5%). Staphylococcus epidermidis (54.1%) and S. aureus (20.0%) were the most common pathogens responsible for catheter infections. HC infections were associated with a low mortality rate (maximum rate of 0.5%). Risk factor analysis of 129 HCs demonstrated that catheter thrombosis was the major risk factor associated with development of catheter infection. Presence of fever, distant infection, neutropenia or antibiotic administration on the day of catheter insertion was not significantly associated with HC infection in this series (although there was a trend suggesting an increased risk of infection of HCs inserted during febrile episodes). Based on observations at our institution and from a review of the literature, tentative recommendations for management of the various types of HC infections are outlined.
doi_str_mv 10.1097/00005792-198407000-00001
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_81134634</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>81134634</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-444af51e6ee8c89da298c25583a15a6a5185cf0c8d62332b0aadd0bf5036c63f3</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRb0AlVL4BKSs2AX8trNEFVCkSmxgbU0dmxoSp8SuEH-P-6CzmZmre2ekg1BF8B3BjbrHpYRqaE0azbEqW72TyBmaYkxFrRrFL9BlSp9FZIryCZpIpoqRTVGzCParh1hZyGuX3ViF6J3NYYipjNUGcnAxp-on5HXVQxc-IkQbXLpC5x665K6PfYbenx7f5ot6-fr8Mn9Y1pZJnGvOOXhBnHROW920QBttqRCaAREgQRAtrMdWt5IyRlcYoG3xygvMpJXMsxm6PdzdjMP31qVs-pCs6zqIbtgmowlhXDJejPpgtOOQ0ui82Yyhh_HXEGx2pMw_KXMitZdIid4cf2xXvWtPwSMm9gd5-mWP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>81134634</pqid></control><display><type>article</type><title>Hickman catheter infections in patients with malignancies</title><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><creator>Press, O W ; Ramsey, P G ; Larson, E B ; Fefer, A ; Hickman, R O</creator><creatorcontrib>Press, O W ; Ramsey, P G ; Larson, E B ; Fefer, A ; Hickman, R O</creatorcontrib><description>The infectious complications associated with implantation of 1,088 Hickman catheters (HCs) in 992 patients reported in 18 published series are presented (including data on 129 previously unreported HCs from our own institution). HCs allow reliable long-term venous access (mean, 92.4 days) with low complication and infection rates (0.30 and 0.14 cases per 100 catheter days, respectively). Exit site infections were the most common form of infection encountered (45.5%), followed by septicemia alone (30.8%), tunnel infections (20.3%), and septic thrombophlebitis (3.5%). Staphylococcus epidermidis (54.1%) and S. aureus (20.0%) were the most common pathogens responsible for catheter infections. HC infections were associated with a low mortality rate (maximum rate of 0.5%). Risk factor analysis of 129 HCs demonstrated that catheter thrombosis was the major risk factor associated with development of catheter infection. Presence of fever, distant infection, neutropenia or antibiotic administration on the day of catheter insertion was not significantly associated with HC infection in this series (although there was a trend suggesting an increased risk of infection of HCs inserted during febrile episodes). Based on observations at our institution and from a review of the literature, tentative recommendations for management of the various types of HC infections are outlined.</description><identifier>ISSN: 0025-7974</identifier><identifier>DOI: 10.1097/00005792-198407000-00001</identifier><identifier>PMID: 6377003</identifier><language>eng</language><publisher>United States</publisher><subject>Acute Disease ; Adolescent ; Adult ; Aged ; Anti-Bacterial Agents - therapeutic use ; Antineoplastic Agents - administration &amp; dosage ; Bacterial Infections - drug therapy ; Bacterial Infections - etiology ; Bone Marrow Transplantation ; Candidiasis - drug therapy ; Candidiasis - etiology ; Catheters, Indwelling - adverse effects ; Enterobacteriaceae Infections - drug therapy ; Enterobacteriaceae Infections - etiology ; Female ; Heart Atria ; Humans ; Infusions, Parenteral ; Leukemia - drug therapy ; Leukemia - therapy ; Male ; Middle Aged ; Risk ; Sepsis - drug therapy ; Sepsis - etiology ; Staphylococcal Infections - drug therapy ; Staphylococcal Infections - etiology ; Staphylococcus epidermidis ; Thrombophlebitis - etiology</subject><ispartof>Medicine (Baltimore), 1984-07, Vol.63 (4), p.189-200</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-444af51e6ee8c89da298c25583a15a6a5185cf0c8d62332b0aadd0bf5036c63f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6377003$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Press, O W</creatorcontrib><creatorcontrib>Ramsey, P G</creatorcontrib><creatorcontrib>Larson, E B</creatorcontrib><creatorcontrib>Fefer, A</creatorcontrib><creatorcontrib>Hickman, R O</creatorcontrib><title>Hickman catheter infections in patients with malignancies</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>The infectious complications associated with implantation of 1,088 Hickman catheters (HCs) in 992 patients reported in 18 published series are presented (including data on 129 previously unreported HCs from our own institution). HCs allow reliable long-term venous access (mean, 92.4 days) with low complication and infection rates (0.30 and 0.14 cases per 100 catheter days, respectively). Exit site infections were the most common form of infection encountered (45.5%), followed by septicemia alone (30.8%), tunnel infections (20.3%), and septic thrombophlebitis (3.5%). Staphylococcus epidermidis (54.1%) and S. aureus (20.0%) were the most common pathogens responsible for catheter infections. HC infections were associated with a low mortality rate (maximum rate of 0.5%). Risk factor analysis of 129 HCs demonstrated that catheter thrombosis was the major risk factor associated with development of catheter infection. Presence of fever, distant infection, neutropenia or antibiotic administration on the day of catheter insertion was not significantly associated with HC infection in this series (although there was a trend suggesting an increased risk of infection of HCs inserted during febrile episodes). Based on observations at our institution and from a review of the literature, tentative recommendations for management of the various types of HC infections are outlined.</description><subject>Acute Disease</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antineoplastic Agents - administration &amp; dosage</subject><subject>Bacterial Infections - drug therapy</subject><subject>Bacterial Infections - etiology</subject><subject>Bone Marrow Transplantation</subject><subject>Candidiasis - drug therapy</subject><subject>Candidiasis - etiology</subject><subject>Catheters, Indwelling - adverse effects</subject><subject>Enterobacteriaceae Infections - drug therapy</subject><subject>Enterobacteriaceae Infections - etiology</subject><subject>Female</subject><subject>Heart Atria</subject><subject>Humans</subject><subject>Infusions, Parenteral</subject><subject>Leukemia - drug therapy</subject><subject>Leukemia - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Risk</subject><subject>Sepsis - drug therapy</subject><subject>Sepsis - etiology</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal Infections - etiology</subject><subject>Staphylococcus epidermidis</subject><subject>Thrombophlebitis - etiology</subject><issn>0025-7974</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><recordid>eNo9kMtOwzAQRb0AlVL4BKSs2AX8trNEFVCkSmxgbU0dmxoSp8SuEH-P-6CzmZmre2ekg1BF8B3BjbrHpYRqaE0azbEqW72TyBmaYkxFrRrFL9BlSp9FZIryCZpIpoqRTVGzCParh1hZyGuX3ViF6J3NYYipjNUGcnAxp-on5HXVQxc-IkQbXLpC5x665K6PfYbenx7f5ot6-fr8Mn9Y1pZJnGvOOXhBnHROW920QBttqRCaAREgQRAtrMdWt5IyRlcYoG3xygvMpJXMsxm6PdzdjMP31qVs-pCs6zqIbtgmowlhXDJejPpgtOOQ0ui82Yyhh_HXEGx2pMw_KXMitZdIid4cf2xXvWtPwSMm9gd5-mWP</recordid><startdate>198407</startdate><enddate>198407</enddate><creator>Press, O W</creator><creator>Ramsey, P G</creator><creator>Larson, E B</creator><creator>Fefer, A</creator><creator>Hickman, R O</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198407</creationdate><title>Hickman catheter infections in patients with malignancies</title><author>Press, O W ; Ramsey, P G ; Larson, E B ; Fefer, A ; Hickman, R O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-444af51e6ee8c89da298c25583a15a6a5185cf0c8d62332b0aadd0bf5036c63f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Acute Disease</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antineoplastic Agents - administration &amp; dosage</topic><topic>Bacterial Infections - drug therapy</topic><topic>Bacterial Infections - etiology</topic><topic>Bone Marrow Transplantation</topic><topic>Candidiasis - drug therapy</topic><topic>Candidiasis - etiology</topic><topic>Catheters, Indwelling - adverse effects</topic><topic>Enterobacteriaceae Infections - drug therapy</topic><topic>Enterobacteriaceae Infections - etiology</topic><topic>Female</topic><topic>Heart Atria</topic><topic>Humans</topic><topic>Infusions, Parenteral</topic><topic>Leukemia - drug therapy</topic><topic>Leukemia - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Risk</topic><topic>Sepsis - drug therapy</topic><topic>Sepsis - etiology</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal Infections - etiology</topic><topic>Staphylococcus epidermidis</topic><topic>Thrombophlebitis - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Press, O W</creatorcontrib><creatorcontrib>Ramsey, P G</creatorcontrib><creatorcontrib>Larson, E B</creatorcontrib><creatorcontrib>Fefer, A</creatorcontrib><creatorcontrib>Hickman, R O</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Press, O W</au><au>Ramsey, P G</au><au>Larson, E B</au><au>Fefer, A</au><au>Hickman, R O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hickman catheter infections in patients with malignancies</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>1984-07</date><risdate>1984</risdate><volume>63</volume><issue>4</issue><spage>189</spage><epage>200</epage><pages>189-200</pages><issn>0025-7974</issn><abstract>The infectious complications associated with implantation of 1,088 Hickman catheters (HCs) in 992 patients reported in 18 published series are presented (including data on 129 previously unreported HCs from our own institution). HCs allow reliable long-term venous access (mean, 92.4 days) with low complication and infection rates (0.30 and 0.14 cases per 100 catheter days, respectively). Exit site infections were the most common form of infection encountered (45.5%), followed by septicemia alone (30.8%), tunnel infections (20.3%), and septic thrombophlebitis (3.5%). Staphylococcus epidermidis (54.1%) and S. aureus (20.0%) were the most common pathogens responsible for catheter infections. HC infections were associated with a low mortality rate (maximum rate of 0.5%). Risk factor analysis of 129 HCs demonstrated that catheter thrombosis was the major risk factor associated with development of catheter infection. Presence of fever, distant infection, neutropenia or antibiotic administration on the day of catheter insertion was not significantly associated with HC infection in this series (although there was a trend suggesting an increased risk of infection of HCs inserted during febrile episodes). Based on observations at our institution and from a review of the literature, tentative recommendations for management of the various types of HC infections are outlined.</abstract><cop>United States</cop><pmid>6377003</pmid><doi>10.1097/00005792-198407000-00001</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-7974
ispartof Medicine (Baltimore), 1984-07, Vol.63 (4), p.189-200
issn 0025-7974
language eng
recordid cdi_proquest_miscellaneous_81134634
source HEAL-Link subscriptions: Lippincott Williams & Wilkins
subjects Acute Disease
Adolescent
Adult
Aged
Anti-Bacterial Agents - therapeutic use
Antineoplastic Agents - administration & dosage
Bacterial Infections - drug therapy
Bacterial Infections - etiology
Bone Marrow Transplantation
Candidiasis - drug therapy
Candidiasis - etiology
Catheters, Indwelling - adverse effects
Enterobacteriaceae Infections - drug therapy
Enterobacteriaceae Infections - etiology
Female
Heart Atria
Humans
Infusions, Parenteral
Leukemia - drug therapy
Leukemia - therapy
Male
Middle Aged
Risk
Sepsis - drug therapy
Sepsis - etiology
Staphylococcal Infections - drug therapy
Staphylococcal Infections - etiology
Staphylococcus epidermidis
Thrombophlebitis - etiology
title Hickman catheter infections in patients with malignancies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T14%3A31%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hickman%20catheter%20infections%20in%20patients%20with%20malignancies&rft.jtitle=Medicine%20(Baltimore)&rft.au=Press,%20O%20W&rft.date=1984-07&rft.volume=63&rft.issue=4&rft.spage=189&rft.epage=200&rft.pages=189-200&rft.issn=0025-7974&rft_id=info:doi/10.1097/00005792-198407000-00001&rft_dat=%3Cproquest_cross%3E81134634%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c360t-444af51e6ee8c89da298c25583a15a6a5185cf0c8d62332b0aadd0bf5036c63f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=81134634&rft_id=info:pmid/6377003&rfr_iscdi=true